变态反应是机体受到细菌、病毒、寄生虫或花粉等抗原性物质刺激后引起的组织损伤或生理功能紊乱,这属于异常的或病理性的免疫反应。用于防治这类疾病的药物被称为抗变态反应药,也即抗过敏药。这类药物主要包括以下几类:
抗组胺药:主要是组胺H1受体拮抗剂,如异丙嗪和苯海拉明等。这些药物通过与效应细胞上的组胺H1受体竞争结合,使组胺无法与其受体结合,从而抑制其引起过敏反应的作用。此外,组胺脱羧抑制剂也属于这一类。
过敏反应介质阻释剂:这类药物能够稳定肥大细胞膜,阻止组胺及其相关的过敏反应介质(如慢反应物质缓激肽等)的释放。例如色甘酸钠即属于此类药物。
其他抗变态反应药:包括钙盐(如氯化钙和葡萄糖酸钙)、脱敏制剂(例如用于粉尘螨的注射液),以及糖皮质激素(如泼尼松等)。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
马来酸非尼拉敏 | pheniramine maleate | 132-20-7 | C4H3O4*C16H21N2 |
|
马来酸阿扎他啶 | Azatadin maleate | 3978-86-7 | C4H4O4*C20H22N2 |
|
马来酸罗托沙敏 | carbinoxamine maleate | 3505-38-2 | C4H4O4*C16H19ClN2O |
|
马来酸溴苯那敏 | RS-brompheniramine maleate | 980-71-2 | C4H4O4*C16H19BrN2 |
|
马来酸右氯苯那敏 | dextrochlorpheniramine maleate | 2438-32-6 | C4H4O4*C16H19ClN2 |
|
马来酸二甲茚定 | dimetindene maleate | 3614-69-5 | C4H4O4*C20H24N2 |
|
非索芬那定 | fexofenadine | 83799-24-0 | C32H39NO4 |
|
非尼拉敏 | pheniramine | 86-21-5 | C16H20N2 |
|
阿司咪唑 | astemizole | 68844-77-9 | C28H31FN4O |
|
阿伐斯汀 | acrivastine | 87848-99-5 | C22H24N2O2 |
|
醋酸罗沙替丁 | Pifatidine | 78628-28-1 | C19H28N2O4 |
|
酒石酸异丁嗪 | trimeprazine tartrate | 4330-99-8 | C4H6O6*2C18H22N2S |
|
赛达斯丁 | setastine | 64294-95-7 | C22H28ClNO |
|
西那利定 | thenalidine | 86-12-4 | C17H22N2S |
|
西替利嗪 | cetirizine | 83881-51-0 | C21H25ClN2O3 |
|
西尼二胺 | <i>N</i>,<i>N</i>-dimethyl-<i>N</i>'-[2]pyridyl-<i>N</i>'-[3]thienylmethyl-ethylenediamine | 91-79-2 | C14H19N3S |
|
茶苯海明 | dimenhydrinate | 523-87-5 | C7H7ClN4O2*C17H21NO |
|
茶氯酸异丙嗪 | (+/-)-dimethyl-(β-phenothiazin-10-yl-isopropyl)-amine; salt of 8-chloro-1,3-dimethyl-3,7-dihydro-purine-2,6-dione | 17693-51-5 | C7H7ClN4O2*C17H20N2S |
|
苯茚胺 | phenindamine | 82-88-2 | C19H19N |
|
苯海拉明 | 2-diphenylmethoxy-N,N-dimethylethanamine | 58-73-1 | C17H21NO |
|
苯托沙敏 | phenyltoloxamine | 92-12-6 | C17H21NO |
|
苄哌苯胺 | bamipine | 4945-47-5 | C19H24N2 |
|
色甘酸 | cromoglicinic acid | 16110-51-3 | C23H16O11 |
|
美喹他嗪 | mequitazine | 29216-28-2 | C20H22N2S |
|
美吡拉敏 | pyrilamine | 91-84-9 | C17H23N3O |
|
盐酸赛庚啶半水合物 | Cyproheptadine hydrochloride monohydrate | 41354-29-4 | C21H24ClNO |
|
盐酸赛庚啶 | cyproheptadine hydrochloride | 969-33-5 | C21H21N*ClH |
|
盐酸苯海拉明 | diphenhydramine hydrochloride | 147-24-0 | C17H22NO*Cl |
|
盐酸氮卓斯汀 | (R)-Azelastine Hydrochloride | 153408-28-7 | C22H25Cl2N3O |
|
盐酸曲普利啶 | hydron;2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine;chloride;hydrate | 6138-79-0 | C19H25ClN2O |
|
盐酸曲吡那敏 | tripelennamine hydrochloride | 154-69-8 | C16H21N3*ClH |
|
盐酸托普帕敏 | dimethyl-(3-phenyl-3-<i>p</i>-tolyl-propyl)-amine; hydrochloride | 3339-11-5 | C18H23N*ClH |
|
盐酸异丙嗪 | phenergan | 58-33-3 | C17H21N2S*Cl |
|
盐酸二氧丙嗪 | 9,9-Dioxopromethazin | 13582-96-2 | C17H20N2O2S |
|
甲硫噻丙铵 | thiazinamium metilsulfate | 58-34-4 | CH3O4S*C18H23N2S |
|
琥珀酸多西拉敏 | doxylamine succinate | 562-10-7 | C4H4O4*C17H24N2O |
|
特非那定 | terfenadine | 50679-08-8 | C32H41NO2 |
|
溴苯那敏 | brompheniramine | 86-22-6 | C16H19BrN2 |
|
溴苯海明 | 2-[(4-bromophenyl)phenylmethoxy]-N,N-dimethylethaneamine | 118-23-0 | C17H20BrNO |
|
洛度沙胺氨丁三醇 | lodoxamide tromethamine | 63610-09-3 | 2C4H11NO3*C11H6ClN3O6 |
|
氯雷他定 | loratadine | 79794-75-5 | C22H23ClN2O2 |
|
氯苯那敏 | Dipikrylamin | 131-73-7 | C12H5N7O12 |
|
氯苯吡醇胺 | 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethylethanamine | 486-16-8 | C16H19ClN2O |
|
氯哌斯汀 | Cloperastine | 3703-76-2 | C20H24ClNO |
|
氯吡林 | Chlorothen | 148-65-2 | C14H18ClN3S |
|
氯吡拉敏 | chloropyramine | 59-32-5 | C16H20ClN3 |
|
氮卓斯汀 | azelastine | 58581-89-8 | C22H24ClN3O |
|
氨来诺 | amlexanox | 68302-57-8 | C16H14N2O4 |
|
比拉斯汀 | Bilastine | 202189-78-4 | C28H37N3O3 |
|
柠檬酸苯托沙敏 | phenyltoloxamine dihydrogen citrate | 1176-08-5 | C6H8O7*C17H21NO |
|